- ORCID iD
- 0000-0003-0052-8852
Show
Sort by
-
Towards standardized human platelet lysate production in Europe : an initiative of the European Blood Alliance
-
- Journal Article
- A1
- open access
GPIbα shedding in platelets is controlled by strict intracellular containment of both enzyme and substrate
-
- Journal Article
- A1
- open access
Intranasal administration of convalescent plasma protects against SARS-CoV-2 infection in hamsters
-
- Journal Article
- A1
- open access
Single step method for high yield human platelet lysate production
-
- Journal Article
- A2
- open access
Multinational analysis of children transfused with pathogen inactivated platelets
-
ADAMTS13 inhibition to treat acquired von Willebrand syndrome during mechanical circulatory support device implantation
-
The need for and challenges of comparing SARS-CoV-2 antibody assays
-
- Journal Article
- A1
- open access
SARS-CoV-2 neutralising antibody testing in Europe : towards harmonisation of neutralising antibody titres for better use of convalescent plasma and comparability of trial data
-
- Journal Article
- A1
- open access
A novel competition ELISA for the rapid quantification of SARS-CoV-2 neutralizing antibodies in convalescent plasma
-
- Journal Article
- A1
- open access
Determination of anti‐ADAMTS13 autoantibody titers in ELISA : influence of ADAMTS13 presentation and autoantibody detection
-
Tuning the surface interactions between single cells and an OSTE+ microwell array for enhanced single cell manipulation
-
- Miscellaneous
- open access
Evaluation of SARS‐CoV‐2 antibody titers and potency for convalescent plasma donation : a brief commentary
-
Immunogenic hotspots in the spacer domain of ADAMTS13 in immune‐mediated thrombotic thrombocytopenic purpura
-
Open ADAMTS13, induced by antibodies, is a biomarker for subclinical immune-mediated thrombotic thrombocytopenic purpura
-
- Journal Article
- A2
- open access
When platelets are left in the cold
-
- Journal Article
- A1
- open access
Platelet Biochemistry and Morphology after Cryopreservation
-
- Journal Article
- A1
- open access
The senotherapeutic nicotinamide riboside raises platelet nicotinamide adenine dinucleotide levels but cannot prevent storage lesion
-
- Journal Article
- A1
- open access
The ice recrystallization inhibitor polyvinyl alcohol does not improve platelet cryopreservation
-
Impact of cold storage on platelets treated with Intercept pathogen inactivation
-
- Journal Article
- A1
- open access
A comparison of haematopoietic stem cells from umbilical cord blood and peripheral blood for platelet production in a microfluidic device
-
- Journal Article
- A1
- open access
Biomolecular consequences of platelet pathogen inactivation methods
-
Comparison between manufacturing sites shows differential adhesion, activation, and GPIbα expression of cryopreserved platelets
-
- Journal Article
- A1
- open access
Major changes of von Willebrand factor multimer distribution in cirrhotic patients with stable disease or acute decompensation
-
- Journal Article
- A1
- open access
Comparison of three commercially available buffy coat pooling sets for the preparation of platelet concentrates
-
- Journal Article
- A1
- open access
High platelet content can increase storage lesion rates following Intercept pathogen inactivation primarily in platelet concentrates prepared by apheresis
-
- Journal Article
- A1
- open access
A microfluidic flow chamber model for platelet transfusion and hemostasis measures platelet deposition and fibrin formation in real-time
-
- Journal Article
- A1
- open access
Microfluidic flow chambers using reconstituted blood to model hemostasis and platelet transfusion in vitro
-
- Journal Article
- A1
- open access
Psoralen and ultraviolet A light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing
-
- Journal Article
- A1
- open access
Persistent aggregates in apheresis platelet concentrates are commonly collected from donors with a history of aggregate donation
-
- Journal Article
- A1
- open access
The contribution of von Willebrand factor-GPIbα interactions to persistent aggregate formation in apheresis platelet concentrates
-
Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions
-
Linker regions and flexibility around the metalloprotease domain account for conformational activation of ADAMTS-13
-
- Journal Article
- A1
- open access
Ultraviolet C light pathogen inactivation treatment of platelet concentrates preserves integrin activation but affects thrombus formation kinetics on collagen in vitro
-
Persistent aggregates in apheresis platelet concentrates
-
Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro
-
Aggregates in platelet concentrates
-
Allosteric activation of ADAMTS13 by von Willebrand factor
(2014) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 111(52). p.18584-18589 -
Screening for HLA antibodies in plateletpheresis donors with a history of transfusion or pregnancy
-
Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion
-
Paired analysis of plasma proteins and coagulant capacity after treatment with three methods of pathogen reduction
-
Nitric oxide levels increase during platelet concentrate production from buffy coats, but not during storage
-
Blood platelet biochemistry
-
Inhibition of von Willebrand factor-platelet glycoprotein Ib interaction prevents and reverses symptoms of acute acquired thrombotic thrombocytopenic purpura in baboons
-
Residues Arg568 and Phe592 contribute to an antigenic surface for anti-ADAMTS13 antibodies in the spacer domain
-
Platelets at work in primary hemostasis
-
Local elongation of endothelial cell-anchored von Willebrand factor strings precedes ADAMTS13 protein-mediated proteolysis
-
Thrombotic thrombocytopenic purpura directly linked with ADAMTS13 inhibition in the baboon (Papio ursinus)
-
The distal carboxyterminal domains of murine ADAMTS13 influence proteolysis of platelet-decorated VWF strings in vivo
-
Inactivation of ADAMTS13 by plasmin as a potential cause of thrombotic thrombocytopenic purpura
-
Active platelet-binding conformation of plasma von Willebrand factor in young women with acute myocardial infarction
-
Mutation of the H-bond acceptor S119 in the ADAMTS13 metalloprotease domain reduces secretion and substrate turnover in a patient with congenital thrombotic thrombocytopenic purpura
-
Multi-step binding of ADAMTS-13 to von Willebrand factor
-
ADAMTS13's tail tale
-
ADAMTS13 in health and disease
-
Inherited traits affecting platelet function
-
ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission
-
Factor XI/ADAMTS13 complexes are quantitatively insignificant in human plasma
-
Decreased ADAMTS-13 (A disintegrin-like and metalloprotease with thrombospondin type 1 repeats) is associated with a poor prognosis in sepsis-induced organ failure
-
ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis
-
Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13
-
Development of monoclonal antibodies that inhibit platelet adhesion or aggregation as potential anti-thrombotic drugs
-
Alteration of ADAMTS13 antigen levels in patients with idiopathic thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura and systemic lupus erythematosus
-
ADAMTS-13 plasma level determination uncovers antigen absence in acquired thrombotic thrombocytopenic purpura and ethnic differences
-
[Determination of the ADAMTS13 antigen and its activity in TTP patients and carriers]
-
[A clinical study of congenital thrombotic thrombocytopenic purpura]
-
Monoclonal antibody IAC-1 is specific for activated α2β1 and binds to amino acids 199 to 201 of the integrin α2 I-domain